The tariff classification of Sertraline Hydrochloride (CAS-79619-96-2) in dosage form, from India
Issued December 5, 2008 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9135
Headings: 3004
Product description
The subject product, Sertraline Hydrochloride, is a medicinal preparation, in tablet and oral suspension form, containing Sertraline Hydrochloride, an antidepressant, as the active ingredient.
CBP rationale
The applicable subheading for the Sertraline Hydrochloride in dosage form will be 3004.90.9135, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents.
Full text
N045897 December 5, 2008 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9135 Mr. Colm Moynihan NorthStar Healthcare Ltd. 3300 Cork Airport Business Park Kinsale Road, Cork Ireland RE: The tariff classification of Sertraline Hydrochloride (CAS-79619-96-2) in dosage form, from India Dear Mr. Moynihan: In your letter dated December 1, 2008, you requested a tariff classification ruling. The subject product, Sertraline Hydrochloride, is a medicinal preparation, in tablet and oral suspension form, containing Sertraline Hydrochloride, an antidepressant, as the active ingredient. The applicable subheading for the Sertraline Hydrochloride in dosage form will be 3004.90.9135, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Budesonide Capsules from India and Perphenazine Tablets from Italy
The tariff classification of Linezolid tablets and Trazodone Hydrochloride tablets in dosage form, from India
The tariff classification of Aripiprazole Orally Disintegrating Tablets in dosage form, from India
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India. Correction to Ruling Number N258062.
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Olanzapine Tablets and Olanzapine Orally Disintegrating Tablets, imported in dosage form, from India
The tariff classification of Duloxetine Hydrochloride Capsules, imported in dosage form, from India
The tariff classification of Duloxetine Delayed Release Capsules, imported in dosage form, from India
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Duloxetine Hydrochloride Capsules (CAS-136434-34-9), imported in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →